January, 18 2024, 12:48pm EDT
![Public Citizen](https://assets.rbl.ms/32012683/origin.png)
Manufacturers of 10 Drugs Slated for Medicare Price Negotiation Spent Billions More on Buybacks, Dividends and Executive Compensation than R&D
While the pharmaceutical industry says that the drug price negotiation provisions under the Inflation Reduction Act will harm research and development, a new report by Public Citizen and Protect our Care reveals that the manufacturers of the first 10 drugs selected for Medicare price negotiation spent $10 billion more on stock buybacks, dividends to shareholders, and executive compensation than they spent on research and development in 2022. According to the report, which analyzes SEC filings and company annual reports, manufacturers spent $107 billion on these activities compared to $97 billion on R&D in 2022. What’s more, executive compensation for these companies was approximately half a billion dollars in 2022.
“The industry tells us that Medicare price negotiations will make it hard to research and develop new drugs. What they leave out is that many are already spending far more to make their executives and shareholders rich than on R&D,” said Peter Maybarduk, Access to Medicines program director at Public Citizen. “When these corporations complain about the impact of price negotiations on innovation, we should be deeply skeptical.”
Additionally, the report notes that researchers and the Congressional Budget Office conclude there is no connection between a drug’s research and development cost and its future price, and that the current price of drugs reflects what companies believe the market will bear in response to their monopolistic pricing power. Additionally, the United States is an outlier that does little to protect its residents from the unfair pricing power of drug companies – and bringing American policy into alignment with those of other countries, including its high-income peers, would not destroy the incentive to innovate new medicines.
“These findings undermine industry claims that reducing corporate profits in Medicare price negotiation will impact capacity to invest in research and developing new drugs,” said Jishian Ravinthiran, researcher with Public Citizen and lead author of the report. “These companies are not strapped for resources, as they spend massive amounts of money on self-enriching activities.”
The report also reveals that manufacturers of the 10 drugs with the highest annual expenditures by payers in Maryland spent $9 billion more on stock buybacks, dividends, and executive compensation than on research and development expenses in 2022. Seven states, starting with Maryland in 2019, have established Prescription Drug Affordability Boards charged with analyzing the excessive costs of prescription drugs and identifying solutions to medicine inaccessibility. As other states consider creating their own Boards with the authority to limit the price of drug transactions, or consider expanding these Boards’ authority to deliver relief to more residents, they can rely on this report’s finding that industry has ample resources to invest in drug innovation.
At a press conference today, Maryland Healthcare for all will kick off a campaign to pass major legislation in 2024 to expand the authority of the Maryland Prescription Drug Affordability Board and continue the work of bringing down high costs for medications.
Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people - not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.
(202) 588-1000LATEST NEWS
BREAKING: Biden to 'Stand Down'; Endorses Kamala Harris
' I want to offer my full support and endorsement for Kamala to be the nominee of our party this year'
Jul 21, 2024
Breaking News...more to come
UPDATE : In response to President Biden’s announcement that he is no longer seeking reelection, MoveOn Political Action Executive Director Rahna Epting released the following statement:
“President Joe Biden‘s legacy is defined by defeating Donald Trump, restoring our nation’s commitment to our democracy, and delivering one of the most impressive domestic policy agendas in modern history. Just like he did in 2020, President Biden is making a tremendous personal sacrifice to preserve our democracy, putting the interest of the American people first, and he has the gratitude of our nation and our millions of members.
“Vice President Harris is tested and respected, and her voice is critically important at this moment. MoveOn and our members have her back and believe that those who share our commitment to winning this election and protecting our futures will do everything in their power to lift her up and stop Trump in his tracks.
MoveOn is more driven than ever to unifying the anti-Trump coalition and defeating Donald Trump and extremist MAGA Republicans once again in 2024. We are all in on electing Kamala Harris and Democrats to the U.S. House and Senate and we look forward to engaging our members and surge voters across the country to rise up and make their voices heard this fall.”
President Joe Biden has made the decision to not run for president. Read his just released statement below.
Keep ReadingShow Less
Israeli Military Strikes Claim Lives of 64 Individuals in a Single Day
'When is enough? When will the war ever end?'
Jul 21, 2024
The local Health Ministry says at least 64 people were killed and 105 injured in Israeli attacks across Gaza in the past 24 hours. Many victims are still under the rubble and on roads, with civil defense crews not able to reach them, it adds.
The Israeli military has launched numerous deadly strikes focused on the Al-Nuseirat refugee camp, including the targeting of multiple UN-run schools housing displaced people.
Nuseirat residents described living in constant fear of being bombed and a deteriorating humanitarian situation.
“The situation is scary,” said Rahma Abu Hajjaj, a 39-year-old mother of five from Nuserirat. “There are no warnings, there are no alarms when homes are bombed, we are hiding all the time and we do not know why they are targeting these homes.”
"We hear the sounds of explosions in Nuseirat and we see the smoke rising from here in Deir Al-Balah, the last refuge you can say and we are being terrorized by the feeling tanks may roll here," Tamer Aburakan, a resident of Gaza City, told
Reuters.
"Where should we go next? The entire Gaza Strip is under fire, and we are being hunted like deer in a forest. When is enough? When will the war ever end?" he said via a chat app.
Israeli Prime Minister Benjamin Netanyahu is due to travel to the US on Monday. Netanyahu is expected to meet with US President Joe Biden on Tuesday afternoon. The next day, he is due to address a joint session of US Congress.
Thousands of people are expected to protest against the visit of Netanyahu for whom the top prosecutor of the International Criminal Court is seeking an arrest warrant for war crimes.
At least 38,983 Palestinians have been killed and 89,727 others injured in Israel's military offensive on Gaza since Oct. 7, Gaza's health ministry said on Sunday, including the 64 people killed in the last 24 hours.
Keep ReadingShow Less
Israel Bombs Yemen Saturday in Escalation with Houthis
The attack came a day after the Houthis claimed responsibility for a drone attack on Tel Aviv
Jul 20, 2024
Houthi-run media say Israeli air strikes Saturday targeted oil storage facilities in the Yemeni port city of Hodeidah and that there are an unspecified number of fatalities and injuries.
The attack came a day after the Houthis claimed responsibility for a drone attack on Tel Aviv that killed one person and struck just yards from a U.S. Embassy branch office.
Israel’s air strikes will not stop the Houthi's military operations in support of the Palestinian people, Houthi political bureau member Mohammed al-Bukhaiti said in a post on X, warning they will instead increase until the war in Gaza ends. “The Zionist entity will pay the price for targeting civilian facilities, and we will meet escalation with escalation,” al-Bukhaiti wrote.
Military and political analyst Elijah Magnier told Al Jazeera, “Is this going to change the course of action of a non-state actor that is motivated to support the people of Gaza? Certainly not,” Magnier said. “They’ve been given a perfect reason to increase the attacks. We have not seen the end of it – far from it,” he said.
In another post on X, the Houthis’ spokesman, Mohammed Abdulsalam, called the Israeli air strikes “a brutal Israeli aggression against Yemen that aims to deepen people’s suffering and to pressure Yemen to stop supporting Gaza.” Abdulsalam called the attack an Israeli “dream that will not come true. We affirm that this brutal aggression will only increase the determination of the Yemeni people and their valiant armed forces to be steadfast and to continue their support for Gaza. The Yemeni people are able to face all challenges for the sake of victory for oppressed Palestine and the people of Gaza, whose cause is the most just on earth.”
Keep ReadingShow Less
Most Popular